Clinical Trial

INTERACT4 Expansion - Validation Study

Study acronym: INTERACT4 Exp
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
As an investigator-initiated and conducted, multi-centre, open-label, single-arm prospective observational trial, INTERACT4 Expansion aims to evaluate the diagnostic accuracy of GFAP measured using a point-of-care device, for identifying ICH in participants presenting with acute stroke-like symptoms in the pre-hospital setting compared with imaging-confirmed ICH.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-13.
Trial Details
NCT Number NCT07231315
Lead Sponsor The George Institute
Conditions Intracerebral Hemorrhage
Enrollment 465 participants
Start Date 2026-02-01
Primary Completion 2026-11-01 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-19